A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
Active, not recruiting · NCT05819866 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy | Cerebral Adrenoleukodystrophy (cALD) | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05819866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Minoryx Therapeutics, S.L. | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Federal University of Sao Paulo | São Paulo | Brazil | 2 |
| Hospital 12 de Octubre | Madrid | Spain | 14 |
| Hospital Austral | Buenos Aires | Argentina | 1 |
| ICM La Pitie Salpetriere | Paris | France | 1 |
| Kennedy Krieger Institute | Baltimore | United States | 41 |
| Klinik und Poliklinik für Neurologie-Leipzig | Leipzig | Germany | 1 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| National Hospital for Neurology and Neurosurgery | London | United Kingdom | 1 |
| Sir Ganga Ram Hospital | New Delhi | India | 26 |
| Stanford University Medical Center | Palo Alto | United States | 1 |
| University of Minnesota | Minneota | United States | 5 |